DELIVERY ORDER

ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00003 TO INCREASE OF FUNDING.

Awarded to MCKESSON CORPORATION

PIID 15B40618FTB140017US · USAspendingBiotechnology & Pharmaceuticals
-$533.8K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation-$533,816sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateSep 7, 2018
Company legal name
MCKESSON CORPORATION
UEI / CAGE
S1RUKWWRYFL6 / Not reported
Parent award
Not reported
Awarding agency
Department of Justice
Subagency
Federal Prison System / Bureau of Prisons
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
6555 STATE HIGHWAY 161, IRVING, DALLAS, TX, 75039
Place of performance
SAN FRANCISCO, SAN FRANCISCO, CA, 94104
Source last modified
Oct 21, 2026

Description

ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00003 TO INCREASE OF FUNDING.

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Contract modified

    ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00003 TO INCREASE OF FUNDING.

    US · usaspendingSource ↗
  2. Value increased

    ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00003 TO INCREASE OF FUNDING.

    US · usaspending$30KSource ↗
  3. Award announced

    ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00001 TO DECREASE FUNDING.

    US · usaspendingSource ↗
  4. Value decreased

    ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00001 TO DECREASE FUNDING.

    US · usaspending-$563.8KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Sep 7, 2018P00003C$29,964.60Not reportedNot reportedESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00003 TO INCREASE OF FUNDING.USAspending ↗
Aug 23, 2018P00002C-$563,780.66Not reportedNot reportedESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00001 TO DECREASE FUNDING.USAspending ↗